| Overview of the matrisome—an inventory of extracellular matrix constituents and functions RO Hynes, A Naba Cold Spring Harbor perspectives in biology 4 (1), a004903, 2012 | 1334 | 2012 |
| The matrisome: in silico definition and in vivo characterization by proteomics of normal and tumor extracellular matrices A Naba, KR Clauser, S Hoersch, H Liu, SA Carr, RO Hynes Molecular & Cellular Proteomics 11 (4), 2012 | 1151 | 2012 |
| The extracellular matrix: Tools and insights for the “omics” era A Naba, KR Clauser, H Ding, CA Whittaker, SA Carr, RO Hynes Matrix Biology 49, 10-24, 2016 | 930 | 2016 |
| Extracellular matrix signatures of human mammary carcinoma identify novel metastasis promoters A Naba, KR Clauser, JM Lamar, SA Carr, RO Hynes elife 3, e01308, 2014 | 427 | 2014 |
| Emerging role for ERM proteins in cell adhesion and migration M Arpin, D Chirivino, A Naba, I Zwaenepoel Cell adhesion & migration 5 (2), 199-206, 2011 | 285 | 2011 |
| Extracellular matrix signatures of human primary metastatic colon cancers and their metastases to liver A Naba, KR Clauser, CA Whittaker, SA Carr, KK Tanabe, RO Hynes BMC cancer 14, 1-12, 2014 | 253 | 2014 |
| Extracellular matrix in lung development, homeostasis and disease Y Zhou, JC Horowitz, A Naba, N Ambalavanan, K Atabai, J Balestrini, ... Matrix Biology 73, 77-104, 2018 | 251 | 2018 |
| Characterization of the extracellular matrix of normal and diseased tissues using proteomics A Naba, OMT Pearce, A Del Rosario, D Ma, H Ding, V Rajeeve, ... Journal of proteome research 16 (8), 3083-3091, 2017 | 205 | 2017 |
| MatrisomeDB: the ECM-protein knowledge database X Shao, IN Taha, KR Clauser, Y Gao, A Naba Nucleic acids research 48 (D1), D1136-D1144, 2020 | 199 | 2020 |
| Comprehensive proteomic characterization of stem cell-derived extracellular matrices H Ragelle, A Naba, BL Larson, F Zhou, M Prijić, CA Whittaker, ... Biomaterials 128, 147-159, 2017 | 152 | 2017 |
| The cancer matrisome: From comprehensive characterization to biomarker discovery AM Socovich, A Naba Seminars in cell & developmental biology 89, 157-166, 2019 | 146 | 2019 |
| A tumor-derived type III collagen-rich ECM niche regulates tumor cell dormancy JS Di Martino, AR Nobre, C Mondal, I Taha, EF Farias, EJ Fertig, A Naba, ... Nature cancer 3 (1), 90-107, 2022 | 143 | 2022 |
| Enrichment of extracellular matrix proteins from tissues and digestion into peptides for mass spectrometry analysis A Naba, KR Clauser, RO Hynes JoVE (Journal of Visualized Experiments), e53057, 2015 | 136 | 2015 |
| Quantitative proteomics identify Tenascin-C as a promoter of lung cancer progression and contributor to a signature prognostic of patient survival V Gocheva, A Naba, A Bhutkar, T Guardia, KM Miller, CMC Li, TL Dayton, ... Proceedings of the National Academy of Sciences 114 (28), E5625-E5634, 2017 | 133 | 2017 |
| Towards definition of an ECM parts list: an advance on GO categories A Naba, S Hoersch, RO Hynes Matrix biology: journal of the International Society for Matrix Biology 31, 371, 2012 | 111 | 2012 |
| MatrixDB: integration of new data with a focus on glycosaminoglycan interactions O Clerc, M Deniaud, SD Vallet, A Naba, A Rivet, S Perez, N Thierry-Mieg, ... Nucleic acids research 47 (D1), D376-D381, 2019 | 109 | 2019 |
| Lamellipodin promotes invasive 3D cancer cell migration via regulated interactions with Ena/VASP and SCAR/WAVE G Carmona, U Perera, C Gillett, A Naba, AL Law, VP Sharma, J Wang, ... Oncogene 35 (39), 5155-5169, 2016 | 96 | 2016 |
| Quantitative proteomic profiling of the extracellular matrix of pancreatic islets during the angiogenic switch and insulinoma progression A Naba, KR Clauser, DR Mani, SA Carr, RO Hynes Scientific reports 7 (1), 40495, 2017 | 94 | 2017 |
| Exploring the extracellular matrix in health and disease using proteomics I Taha, A Naba Essays in Biochemistry, 2019 | 93 | 2019 |
| Proteomic characterization of human multiple myeloma bone marrow extracellular matrix SV Glavey, A Naba, S Manier, K Clauser, S Tahri, J Park, MR Reagan, ... Leukemia 31 (11), 2426-2434, 2017 | 90 | 2017 |
Sebastian HoerschInvestigator, Novartis Institutes for Biomedical ResearchVerified email at novartis.com
